Programa de Pós-Graduação em Saúde Coletiva, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo. Av. Marechal Campos 1.468, Maruípe. 29040-091 Vitória ES Brasil.
Instituto de Ciência Política, Universidade de Brasília. Brasília DF Brasil.
Cien Saude Colet. 2022 Mar;27(3):951-956. doi: 10.1590/1413-81232022273.21822021. Epub 2022 Jan 7.
This paper reflects on the vaccination campaign against COVID-19 in Brazil in light of the consideration of scientific evidence in the decision-making process. Brazil has one of the largest and most complete vaccination programs in the world, the National Immunization Program (Programa Nacional de Imunizações or PNI). Unfortunately, in the current context, with the political interference of the federal government, the PNI lost its role in conducting the vaccination campaign against COVID-19. Despite being a vaccination campaign with a lot of potential and one of the most accepted by the population among countries in the world, it presented many problems and left several gaps in the Brazilian scenario. In this sense, it is essential that the quality scientific evidence produced during this period can guide a constant remodeling of the vaccination strategy. Four points deserve to be highlighted: 1) the interval between doses; 2) the interchangeability between vaccines; 3) vaccination in children and adolescentes; and 4) the need for better evidence to define the vaccination strategy in certain groups and age groups.
本文反思了在考虑决策过程中的科学证据的情况下,巴西针对 COVID-19 的疫苗接种运动。巴西拥有世界上最大和最完备的疫苗接种计划之一,国家免疫计划(Programa Nacional de Imunizações 或 PNI)。不幸的是,在当前背景下,联邦政府的政治干预使 PNI 在开展 COVID-19 疫苗接种运动方面失去了作用。尽管这是一次具有很大潜力的疫苗接种运动,也是世界各国中最受民众接受的疫苗接种运动之一,但它还是出现了许多问题,并在巴西的接种场景中留下了一些空白。在这方面,至关重要的是在此期间产生的高质量科学证据能够指导不断调整疫苗接种策略。有四点值得强调:1)剂量间隔;2)疫苗的可互换性;3)儿童和青少年的接种;4)需要更好的证据来确定某些群体和年龄组的疫苗接种策略。